Omega-3 Fish Oil (EPA & DHA)

Omega-3 fatty acids are structural building blocks of brain tissue, and the body cannot make the long-chain forms efficiently on its own. They’re worth understanding as a supportive nutrient — reasonable to discuss with your doctor as a complement to professional care, and useful if your diet is low in oily fish — but not a replacement for treatment. If you’re struggling, please see our support resources and medical disclaimer.

Why EPA, specifically

Of the two main marine omega-3s, EPA is the one mood research keeps returning to. A 2011 meta-analysis by Sublette and colleagues found that supplements in which EPA made up at least 60% of total EPA+DHA were associated with benefit in depression, while DHA-predominant formulas were not — a threshold later meta-analyses have largely echoed. A 2023 systematic review of ten randomized trials reached a similar place: EPA-enriched formulas at ≥60% of total EPA+DHA, in the range of 1–2 g of EPA per day, showed a modest reduction in depression severity, while doses of 2 g/day or more did not add benefit.

This is why “more milligrams” isn’t automatically better, and why the ratio matters as much as the dose.

What the evidence actually shows

It’s worth being honest about the size and consistency of the effect, because it’s easy to overstate. For a fuller walk-through of the trials, see our deeper review of the omega-3 and mood research.

On the supportive side, a 2019 meta-analysis in Translational Psychiatry pooled 26 trials and around 2,160 participants and found a small but statistically significant overall benefit of omega-3s on depressive symptoms. A 2016 meta-analysis and meta-regression focused specifically on diagnosed major depressive disorder pointed in a similar direction, while flagging how much the dose, EPA:DHA ratio, and study quality moved the results.

On the cautionary side, the 2021 Cochrane review — the most rigorous synthesis available — concluded the evidence is far from conclusive, with substantial heterogeneity between studies: little to no effect in people with mild symptoms, and possible benefit mainly in more severe depression. And the large VITAL-DEP trial (over five years of follow-up in older adults) found omega-3 supplements did not prevent depression or improve mood versus placebo. A 2025 meta-analysis landed in the middle: a longer course (more than eight weeks) of 1,000–1,500 mg/day at an EPA:DHA ratio between 1:1 and 2:1 looked most favorable, but omega-3s were not superior to placebo on response or remission rates.

The fair summary: a genuine but modest signal, strongest for EPA-predominant formulas in people with established (not mild) low mood, and not a tool for preventing depression. That’s why this product carries a Moderate evidence rating, not a higher one.

How to read a fish oil label

The number that matters is combined EPA + DHA per serving, not the headline “fish oil” figure on the front — a “1,000 mg fish oil” softgel may contain only 300 mg of actual EPA+DHA. Three things separate a strong oil from a weak one:

• EPA proportion — for mood specifically, look for EPA at roughly ≥60% of total EPA+DHA.
• Concentration — how much of the oil is genuinely EPA+DHA, so each softgel delivers an efficient dose. Codex labels oils above 50% EPA+DHA by weight “highly concentrated”; premium products commonly sit in the 60–80% range.
• Oxidation & purity testing — independent verification such as an IFOS rating or a published TOTOX value within GOED limits. Rancid oil is the real quality problem, and it’s the one with an actual standard behind it.

Triglyceride-form or enteric-coated oils also help if fishy aftertaste bothers you. Omega-3s also pair sensibly with the other foundational mood-support nutrients — notably vitamin D and magnesium — if your diet or bloodwork suggests you’re low.

FAQ

How long until it works? Mood-related research typically runs over weeks to a few months, not days.

EPA or DHA — which matters for mood? The trials that show benefit lean heavily on EPA-predominant formulas (EPA ≥60% of total EPA+DHA). DHA-dominant formulas have generally not shown the same effect. This is general information, not a treatment recommendation.

Is a higher “fish oil mg” number better? Not necessarily — compare combined EPA+DHA and the EPA proportion, not the total oil figure. Past about 2 g of EPA per day, the research doesn’t show added benefit for mood.

Can it replace my antidepressant or therapy? No. Omega-3s are studied as a supportive nutrient alongside professional care, not a substitute for it. If you’re struggling, please reach out via our support resources.

Sources

1. Sublette ME, et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011;72(12):1577–1584. doi:10.4088/JCP.10m06634
2. Liao Y, et al. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Transl Psychiatry. 2019;9:190. https://www.nature.com/articles/s41398-019-0515-5
3. Mocking RJT, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016;6:e756. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872453/
4. Appleton KM, et al. Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev. 2021;11:CD004692. doi:10.1002/14651858.CD004692.pub5
5. Okereke OI, et al. Effect of long-term supplementation with marine omega-3 fatty acids vs placebo on risk of depression (VITAL-DEP). JAMA. 2021;326(23):2385–2394. doi:10.1001/jama.2021.21187
6. Kong L, et al. Exploration of the optimized portrait of omega-3 polyunsaturated fatty acids in treating depression: a meta-analysis of randomized controlled trials. J Affect Disord. 2025. https://www.sciencedirect.com/science/article/abs/pii/S0165032725003441